Cyrus Biotechnology, Inc. — Form D

Cyrus Biotechnology, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-27. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Javier CastellanosExecutive OfficerSeattle, WA
Jason SmithDirectorEXTON, PA
Jason SmithRelated PersonEXTON, PA
Javier CastellanosDirectorSeattle, WA
Javier CastellanosPromoterSeattle, WA
Yifan SongDirectorSEATTLE, WA
Yifan SongExecutive OfficerSEATTLE, WA
Yifan SongPromoterSEATTLE, WA
Yifan SongRelated PersonSEATTLE, WA
Mark BenjaminExecutive OfficerSEATTLE, WA
Mark BenjaminRelated PersonSEATTLE, WA
Anthony ManningDirectorSEATTLE, WA
Anthony ManningRelated PersonSEATTLE, WA
Lucas NivonDirectorSEATTLE, WA
Lucas NivonExecutive OfficerSEATTLE, WA
Lucas NivonPromoterSEATTLE, WA
Lucas NivonRelated PersonSEATTLE, WA
Ramakrishna SatyavoluDirectorSEATTLE, WA
Ramakrishna SatyavoluRelated PersonSEATTLE, WA
Chad WaiteDirectorSEATTLE, WA
Chad WaiteRelated PersonSEATTLE, WA
Eric BellDirectorMountain View, CA
Gus TaiDirectorLong Island City, NY
Nivon LucasDirectorSeattle, WA
Nivon LucasExecutive OfficerSeattle, WA

Other filings by this issuer (12)

FiledFormOfferingSold
2026-05-08D/A$3.0M$1.5M
2025-07-16D$1.5M$1.1M
2024-12-31D$3.5M$3.2M
2024-02-29D$4.0M$2.7M
2021-12-02D/A$19.4M$18.4M
2021-10-06D/A$15.9M$15.9M
2021-07-07D$12.9M$9.1M
2020-09-17D$1.5M$1.1M
2017-02-21D$1.3M$1.0M
2016-11-16D$500K$490K
2016-04-06D$575K$535K
2015-05-06D$850K$850K

More